FULC CIK: 1680581

Fulcrum Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−78.5
FY22:
−97.1
FY23:
−91.0
FY24:
−2.22
FY25:
−60.1
Change from FY21 to FY25
millions USD
FY21:
−130
FY22:
12.4
FY23:
−36.7
FY24:
32.2
FY25:
30.7
Change from FY21 to FY25
millions USD
FY21:
187
FY22:
84.3
FY23:
118
FY24:
2.75
FY25:
169
millions USD
FY21:
−21.6
FY22:
−0.31
FY23:
−9.54
FY24:
32.8
FY25:
139
(positive)
Change from FY21 to FY25
millions USD
FY21:
−80.2
FY22:
−99.0
FY23:
−91.5
FY24:
−2.50
FY25:
−60.4

All amounts in millions USD Data source:SEC EDGAR